![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Actas Urol Esp (Engl Ed) |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Electronic cigarette: is it a risk factor for the development of bladder cancer?
Actas Urol Esp (Engl Ed). 2023 Apr 20:S2173-5786(23)00047.
PubMed
Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of
Nanoporter-Encased Hydrogel Eradicates Bladder Carcinoma.
Adv Sci (Weinh). 2023;10:e2206893.
PubMed
Abstract available
Adherence to guidelines in the follow-up of non-muscle-invasive bladder cancer
among urology trainers and trainees in Jordan: a cross-sectional study.
Ann Med Surg (Lond). 2023;85:763-766.
PubMed
Abstract available
Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in
Advanced Urothelial Carcinoma.
Anticancer Res. 2023;43:2119-2126.
PubMed
Abstract available
Ectopic prostate tissue at the bladder trigone accompanied by cystitis
glandularis and hemorrhage detected by multiparametric MRI.
Asian J Androl. 2023;25:438-439.
PubMed
Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of
Urinary Bladder Cancer.
Asian Pac J Cancer Prev. 2023;24:1137-1141.
PubMed
Abstract available
Oncological and safety profiles in patients undergoing simultaneous transurethral
resection (TUR) of bladder tumour and TUR of the prostate.
BJU Int. 2023;131:571-580.
PubMed
Abstract available
Reply to Huseyin Besiroglu's Letter to the editor regarding the article 'Do we
need repeat transurethral resection after en-bloc resection for pathological T1
bladder cancer?'.
BJU Int. 2023 Apr 24. doi: 10.1111/bju.16035.
PubMed
Symptoms and signs of urogenital cancer in primary care.
BMC Prim Care. 2023;24:107.
PubMed
Abstract available
Serum lactate dehydrogenase level predicts the prognosis in bladder cancer
patients.
BMC Urol. 2023;23:65.
PubMed
Abstract available
The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or
Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center
Study.
Cancer Control. 2023;30:10732748231173475.
PubMed
Abstract available
Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics
and survival: A population-based nation-wide study in the Bladder Cancer Data
Base Sweden (BladderBaSe).
Cancer Med. 2023 Apr 25. doi: 10.1002/cam4.5981.
PubMed
Abstract available
How has the COVID-19 pandemic affected patients with primary bladder cancer?
Cir Cir. 2023;91:204-211.
PubMed
Abstract available
Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve
Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer.
Clin Genitourin Cancer. 2023 Mar 23:S1558-7673(23)00066.
PubMed
Abstract available
NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis
of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
Environ Toxicol. 2023 Apr 23. doi: 10.1002/tox.23796.
PubMed
Abstract available
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid
tumors: a phase II, open-label, multicenter, multicohort study.
ESMO Open. 2023;8:100877.
PubMed
Abstract available
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development
targeting mucosal immunity.
Eur J Cancer. 2023;187:58-64.
PubMed
Abstract available
Discovery of a novel dual functional phenylpyrazole-styryl hybrid that induces
apoptotic and autophagic cell death in bladder cancer cells.
Eur J Med Chem. 2023;254:115335.
PubMed
Abstract available
VI-RADS for the diagnosis and management of urinary bladder cancer.
Eur Radiol. 2023 Apr 28. doi: 10.1007/s00330-023-09677.
PubMed
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant
Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
Eur Urol Oncol. 2023 Apr 20:S2588-9311(23)00074.
PubMed
Abstract available
Sarcopenia Predicts Disease Progression in Patients with T1 High-grade
Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus
Calmette-Guerin: Implications for Decision-making?
Eur Urol Open Sci. 2023;50:17-23.
PubMed
Abstract available
Circular RNA Ubiquitin-associated Protein 2 Silencing Suppresses Bladder Cancer
Progression by Downregulating DNA Topoisomerase 2-alpha Through Sponging miR-496.
Eur Urol Open Sci. 2023;50:31-42.
PubMed
Abstract available
Recent advances in the understanding of urothelial tumorigenesis.
Expert Rev Anticancer Ther. 2023;23:485-493.
PubMed
Abstract available
Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder
microbiome in patients with non-muscle invasive bladder cancer.
Front Cell Infect Microbiol. 2023;13:1125809.
PubMed
Abstract available
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer
revealing the association with tumor immune microenvironment and prognosis.
Front Genet. 2023;14:1097179.
PubMed
Abstract available
Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through
altering FGFR2 splicing and macrophage polarization.
Front Immunol. 2023;14:1161273.
PubMed
Abstract available
A reevaluation of selected mortality risks in the updated NCI/NIOSH acrylonitrile
cohort study.
Front Public Health. 2023;11:1122346.
PubMed
Abstract available
MTX-211 Inhibits GSH Synthesis through Keap1/NRF2/GCLM Axis and Exerts Antitumor
Effects in Bladder Cancer.
Int J Mol Sci. 2023;24:7608.
PubMed
Abstract available
YTHDF1 Promotes Bladder Cancer Cell Proliferation via the
METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
Int J Mol Sci. 2023;24:6905.
PubMed
Abstract available
Progress in the treatment of urethral adenocarcinoma.
J Cancer Res Clin Oncol. 2023;149:2693-2698.
PubMed
Abstract available
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in
Patients with Bladder Cancer After Radical Cystectomy.
J Inflamm Res. 2023;16:1733-1744.
PubMed
Abstract available
STIL/AURKA axis promotes cell proliferation by influencing primary cilia
formation in bladder cancer.
J Transl Med. 2023;21:281.
PubMed
Abstract available
A prognostic model for bladder cancer based on cytoskeleton-related genes.
Medicine (Baltimore). 2023;102:e33538.
PubMed
Abstract available
Altered Glycosylation in Progression and Management of Bladder Cancer.
Molecules. 2023;28:3436.
PubMed
Abstract available
[Intravesical instillation of bacillus Calmette-Guerin for non-muscle invasive
bladder cancer: outcomes of 421 patients in a single center].
Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:488-494.
PubMed
Abstract available
DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by
stabilizing MYC.
Nat Commun. 2023;14:2421.
PubMed
Abstract available
Expression-based subtypes define pathologic response to neoadjuvant
immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Nat Commun. 2023;14:2126.
PubMed
Abstract available
Impact of Minimally Invasive Approach to Radical Cystectomy in Bladder Cancer
Patients with Malnutrition.
Nutr Cancer. 2023 Apr 26:1-6. doi: 10.1080/01635581.2023.2202432.
PubMed
Abstract available
[Current diagnostic and treatment strategies for urachal cancer].
Orv Hetil. 2023;164:602-609.
PubMed
Abstract available
PET Imaging in Bladder Cancer: An Update and Future Direction.
Pharmaceuticals (Basel). 2023;16:606.
PubMed
Abstract available
Natural Products as New Approaches for Treating Bladder Cancer: From Traditional
Medicine to Novel Drug Discovery.
Pharmaceutics. 2023;15:1117.
PubMed
Abstract available
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated
Review of the Literature.
Pharmacoeconomics. 2023 Apr 23. doi: 10.1007/s40273-023-01273.
PubMed
Abstract available
Cucurbitacin IIb Extracted from Hemsleya penxianensis Induces Cell Cycle Arrest
and Apoptosis in Bladder Cancer Cells by Regulating Cell Cycle Checkpoints and
Mitochondrial Apoptotic Pathway.
Plant Foods Hum Nutr. 2023 Apr 22. doi: 10.1007/s11130-023-01058.
PubMed
Abstract available
Expression of Concern: The prognostic significance of long noncoding RNAs in
bladder cancer: A meta-analysis.
PLoS One. 2023;18:e0284938.
PubMed
Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An
overview of systematic reviews and meta-analyses.
Prog Urol. 2023 Apr 21:S1166-7087(23)00083-0. doi: 10.1016/j.purol.2023.
PubMed
Abstract available
Cost of Bladder Cancer Care: A Single Centre Comparison of Radical Cystectomy and
Trimodal Therapy.
Urol Pract. 2023 Apr 4:101097UPJ0000000000000403.
PubMed
Abstract available
[Research in bladder cancer: translation into the clinic-report of 13th annual
meeting of the German Research Group on Bladder Cancer (DFBK) in Berlin].
Urologie. 2023 Apr 28. doi: 10.1007/s00120-023-02093.
PubMed
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by